secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0001213900-24-011098
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics adopts incentive compensation plan for salaried employees and executive officers
--------------------------------------------------------------------------------

- Plan adopted Feb 6, 2024, effective retroactively to Oct 1, 2023, for all salaried employees including executive officers.
- Bonuses based on Performance Goals tied to individual performance and company milestones; CEO sets goals, Board approves.
- Award formula uses percentage of salary multiplied by weighted percentages for individual and company performance; leadership accountability weighting varies by level.
- Payments made on or about March 31 of following year; subject to clawback policy adopted Oct 23, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000121390024011098/0001213900-24-011098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000121390024011098/ea193020-8k_intensity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-011098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer